Global Western Blotting Market Size (2024 - 2029)

The western blotting market is projected to experience significant growth over the forecast period, driven by the increasing prevalence of chronic diseases, expanding research activities in the biotechnology and pharmaceutical sectors, and heightened R&D investments. The market's expansion is further supported by advancements in western blotting techniques and technologies, which have enhanced the specificity, cost-effectiveness, and ease of use of the test. Despite these positive trends, the market's growth may be constrained by the availability of alternative methods and concerns regarding accuracy.

Market Size of Global Western Blotting Industry

Picture2_Neuroendocrine Tumor Treatment Market
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 6.50 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Low

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Western Blotting Market Analysis

The western blotting market is expected to register a CAGR of 6.5% over the forecast period (2022-2027).

COVID-19 had a significant impact on the western blotting market due to the unexpected spread. For instance, as per the article published in 2020 under the title 'COVID-19: Is there a role for Western blots and skin testing for determining immunity and development of a vaccine?', for diagnostic purposes and to assess immunity, combining serologic testing, that includes Western blots, along with skin testing using SARS-CoV-2 antigens for measuring DTH reactions, was likely to be beneficial. When examining the humoral immune response in patients recovering from COVID-19, the Western blot technique was anticipated to be helpful for locating immunogenic antigens that were likely to be utilized for vaccine development. Hence, as per the factors mentioned above, COVID-19 had a notable impact on the western blotting market.

The western blotting market is majorly driven by factors such as the rising burden of chronic diseases across the globe, growing research activities in the biotech and pharma sector, and raised R&D investment done by pharmaceutical and biotechnology companies. For instance, as per the 2022 update from the Centers for Disease Control and Prevention (CDC), six in ten Americans live with at least one chronic disease, like heart disease and stroke, cancer, or diabetes. These and other chronic diseases are the leading causes of death and disability in America, and they are also a leading driver of health care costs.

Western blotting is a widely known and used test that is used in cell and molecular biology. With the help of this test, one can detect the specific type of protein from the complex mixture of proteins that are extracted from the cell. This test has gained attraction in the market due to its specificity, low cost, and ease of use.

Despite the technique that has evolved since its inception, there have been several advancements in this technique that occurred in the last decade. For instance, as per the article published in 2021 under the title 'Emerging techniques of western blotting for purification and analysis of protein', the arrival of western blotting kits (Pierce Fast of Thermo Scientific) and simplified processes (Western Workflow of Bio-Rad's V3) were open to creating western blotting quicker and more quantifiable. In the past 5-year progress was made in the prepping of gel, imagers of fluorescence, chemiluminescence, and fluorescent antibodies as companies expended a large sum each year on the Western Blotting methodology. Micro fluidical systems significantly lower the duration of time and number of reagents and antibodies needed for western blotting. Those technologies were also allowed to adjust to high-performance systems. Hence, owing to the certain characteristics of the western blot test, the market is believed to witness considerable growth over the forecast period.

As a result of the factors mentioned, the studied market is anticipated to grow throughout the analysis period. However, the alternatives for western blot and accuracy issues restrain the market growth.

Western Blotting Industry Segmentation

As per the scope of the report, the western blot is an analytical technique that is used in molecular biology, immunogenetics, and other disciplines of diagnostics for the identification of specific proteins from the sample of tissue homogenate or extract. The Western Blotting Market is segmented by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics, Others) End Users (Academia and Research Institutes, Diagnostic Centers, Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product
Instruments
Gel Electrophoresis Instruments
Blotting Systems
Imagers
Chemiluminescent Imagers
Fluorescent Imagers
Others
Consumables
Reagents
Kits
By Application
Biomedical & Biochemical Research
Disease Diagnostics
Others
By End-User
Academia and Research Institutes
Diagnostic Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Western Blotting Market Size Summary

The western blotting market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the rising investment in research and development within the pharmaceutical and biotechnology sectors. This technique, widely used in cell and molecular biology, offers specificity, cost-effectiveness, and ease of use, making it a preferred choice for detecting specific proteins from complex mixtures. The market's expansion is further supported by advancements in technology, such as the development of western blotting kits and simplified processes, which have enhanced the speed and quantifiability of the tests. Despite the presence of alternative methods and accuracy concerns, the demand for western blotting in medical diagnostics, particularly for diseases like HIV, Lyme disease, and hepatitis, continues to bolster market growth.

In North America, the market is expected to experience robust growth due to the high prevalence of chronic diseases and the region's strong focus on healthcare innovation. The increasing healthcare costs and the need for early diagnosis of chronic conditions are likely to drive the adoption of western blotting techniques. Additionally, product launches and strategic collaborations among major players, such as Thermo Fisher Scientific, Bio-Rad Laboratories, and Merck & Co., are contributing to the market's expansion. These companies are continuously enhancing their product offerings to meet the growing demand for advanced diagnostic solutions. As the market evolves, it is anticipated that smaller companies will also enter the space, further intensifying competition and driving innovation.

Explore More

Global Western Blotting Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Proteomics Market Across the Globe

      2. 1.2.2 Increasing R&D Investment by the Pharma and Biotech Companies

      3. 1.2.3 Wide Applications of the Western Blot Test

    3. 1.3 Market Restraints

      1. 1.3.1 Availability of the Alternatives for Western Blot

      2. 1.3.2 Accuracy Issues

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product

      1. 2.1.1 Instruments

        1. 2.1.1.1 Gel Electrophoresis Instruments

        2. 2.1.1.2 Blotting Systems

        3. 2.1.1.3 Imagers

          1. 2.1.1.3.1 Chemiluminescent Imagers

          2. 2.1.1.3.2 Fluorescent Imagers

          3. 2.1.1.3.3 Others

      2. 2.1.2 Consumables

        1. 2.1.2.1 Reagents

        2. 2.1.2.2 Kits

    2. 2.2 By Application

      1. 2.2.1 Biomedical & Biochemical Research

      2. 2.2.2 Disease Diagnostics

      3. 2.2.3 Others

    3. 2.3 By End-User

      1. 2.3.1 Academia and Research Institutes

      2. 2.3.2 Diagnostic Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Western Blotting Market Size FAQs

The Global Western Blotting Market is projected to register a CAGR of 6.5% during the forecast period (2024-2029)

Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Merck & Co., Inc., and Danaher Corporation (Cytiva) are the major companies operating in the Global Western Blotting Market.

Western Blotting Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)